Dacarbazine medac 1000 mg infuusiokuiva-aine, liuosta varten Finland - finska - Fimea (Suomen lääkevirasto)

dacarbazine medac 1000 mg infuusiokuiva-aine, liuosta varten

medac gesellschaft fÜr klinische spezialprÄparate mbh - dacarbazine - infuusiokuiva-aine, liuosta varten - 1000 mg - dakarbatsiini

Adrenalin Aguettant 0.1 mg/ml injektioneste, liuos, esitäytetty ruisku Finland - finska - Fimea (Suomen lääkevirasto)

adrenalin aguettant 0.1 mg/ml injektioneste, liuos, esitäytetty ruisku

laboratoire aguettant - adrenaline tartrate - injektioneste, liuos, esitäytetty ruisku - 0.1 mg/ml - adrenaliini

LIDOCAINE ARISTO 10 mg/ml injektioneste, liuos Finland - finska - Fimea (Suomen lääkevirasto)

lidocaine aristo 10 mg/ml injektioneste, liuos

aristo pharma gmbh - lidocaini hydrochloridum monohydricum - injektioneste, liuos - 10 mg/ml - lidokaiini

LIDOCAINE ARISTO 20 mg/ml injektioneste, liuos Finland - finska - Fimea (Suomen lääkevirasto)

lidocaine aristo 20 mg/ml injektioneste, liuos

aristo pharma gmbh - lidocaini hydrochloridum monohydricum - injektioneste, liuos - 20 mg/ml - lidokaiini

Nanogam 100 mg/ml infuusioneste, liuos Finland - finska - Fimea (Suomen lääkevirasto)

nanogam 100 mg/ml infuusioneste, liuos

prothya biosolutions netherlands b.v. - human normal immunoglobulin - infuusioneste, liuos - 100 mg/ml - ihmisen normaali immunoglobuliini intravaskulaariseen käyttöön

Adrenalin Martindale Pharma 0.1 mg/ml injektioneste, liuos Finland - finska - Fimea (Suomen lääkevirasto)

adrenalin martindale pharma 0.1 mg/ml injektioneste, liuos

ethypharm - adrenaline tartrate - injektioneste, liuos - 0.1 mg/ml - adrenaliini

Ultomiris Europeiska unionen - finska - EMA (European Medicines Agency)

ultomiris

alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - selektiiviset immunosuppressantit - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.

Bupropion Accord 300 mg säädellysti vapauttava tabletti Finland - finska - Fimea (Suomen lääkevirasto)

bupropion accord 300 mg säädellysti vapauttava tabletti

accord healthcare b.v. - bupropion hydrochloride - säädellysti vapauttava tabletti - 300 mg - bupropioni

ZENON 10 mg / 10 mg tabletti, kalvopäällysteinen Finland - finska - Fimea (Suomen lääkevirasto)

zenon 10 mg / 10 mg tabletti, kalvopäällysteinen

sanofi oy - rosuvastatinum calcicum,ezetimibum - tabletti, kalvopäällysteinen - 10 mg / 10 mg - rosuvastatiini ja etsetimibi

ZENON 20 mg / 10 mg tabletti, kalvopäällysteinen Finland - finska - Fimea (Suomen lääkevirasto)

zenon 20 mg / 10 mg tabletti, kalvopäällysteinen

sanofi oy - ezetimibum,rosuvastatinum calcicum - tabletti, kalvopäällysteinen - 20 mg / 10 mg - rosuvastatiini ja etsetimibi